The weak efficacy of colistin monotherapy in treating infections with the colistin-susceptible strain was significantly improved when combined with IgM-IG in terms of bacterial clearance from the lungs and blood and the bacteraemia and mortality rates. This evidence concerns the gene CD40LG and infection.